adrenal insufficiency
Endocrinology · 2021–2021
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| hydrocortisone Replacement therapy of adrenal insufficiency in patients aged six years or younger, or in patients aged six years or older with swallowing difficulties or… | Jul 2021 | Recommended with restriction | 20 individuals Support Group · Australasian Paediatric Endocrine Group · Endocrine Nurses Society of Australia and the CAH Support Group · CAH Support Group Australia |
Who spoke
Support Group · Australasian Paediatric Endocrine Group · Endocrine Nurses Society of Australia and the CAH Support Group · CAH Support Group Australia
What the PBS pays
$5M in government benefit over 2024–25, across 279,864 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| hydrocortisone | $5.4M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.